Recent studies have shown that stress and damage induced by nCRT combined with a PD-L1 inhibitor in tumor cells can upregulate stress ligands (such as MICA/B) on the surface of tumor cells, thereby enhancing NK cell recognition and killing ability (36). This evidence concerns the gene MICA and neoplasm.